CRISPR-Cas9 targeting of G-Quadruplex DNA in ADH1 promoter highlights its role in transcriptome and metabolome regulation
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf853 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Ikenna Obi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry and Biophysics, Umeå University, Umeå 901 87, Sweden. Hauptthemen laut MEDLINE: G-Quadruplexes, Promoter Regions, Genetic, CRISPR-Cas Systems, Schizosaccharomyces. Die Arbeit nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Cancer Society, Wenner-Gren Foundations, Insamlingsstiftelsen at Umeå University.
Abstract (Originalsprache)
G-quadruplex (G4) structures are critical regulators of gene expression, yet the role of an individual G4 within its native chromatin remains underexplored, especially outside human systems. Here, we used CRISPR-Cas9 to introduce guanine-to-thymine mutations at a G4-forming motif within the adh1+ promoter in yeast Schizosaccharomyces pombe, creating two mutant strains: one with G4-only mutations and another with both G4 and TATA-box mutations. Chromatin immunoprecipitation using BG4 antibody confirmed reduced G4 enrichment in both mutants, validating G4 structure formation in the wild-type chromatin. Detailed characterizations demonstrated that the G4 mutations alter its dynamics without fully preventing its formation. These mutations significantly reduce adh1 transcript levels, with G4 TATA-box mutant causing the strongest transcriptional suppression. This indicates a positive regulatory role for the G4 structure in transcription. Furthermore, both mutants displayed altered transcriptomic profiles, particularly impacting the oxidoreductase pathway. Metabolomic analyses by mass spectrometry further highlighted substantial disruptions in NAD+/NADH metabolism, a key energy reservoir for metabolic regulation. These results highlight that tuning G4 dynamics, without abolishing the structure, can still profoundly affect gene expression and metabolism, unlike prior studies on the human MYC promoter that disrupted G4 formation. This represents the first such finding in yeast.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Biochemistry and Biophysics, Umeå University, Umeå 901 87, Sweden.
- Science for Lab Laboratory, Umeå University, Umeå, Sweden.
ORCID-Profile: Ikenna Obi, Pallabi Sengupta, Nasim Sabouri
Förderung
- Swedish Cancer Society
- Wenner-Gren Foundations
- Insamlingsstiftelsen at Umeå University
- NIMH NIH HHS
- Swedish Research Council
- Knut and Alice Wallenberg Foundations
Zitieren
APA
Obi, I., Sengupta, P., & Sabouri, N. (2025). CRISPR-Cas9 targeting of G-Quadruplex DNA in ADH1 promoter highlights its role in transcriptome and metabolome regulation. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf853
Vancouver
Obi I, Sengupta P, Sabouri N. CRISPR-Cas9 targeting of G-Quadruplex DNA in ADH1 promoter highlights its role in transcriptome and metabolome regulation. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf853
BibTeX
@article{Obi2025,
author = {Obi, Ikenna and Sengupta, Pallabi and Sabouri, Nasim},
title = {CRISPR-Cas9 targeting of G-Quadruplex DNA in ADH1 promoter highlights its role in transcriptome and metabolome regulation},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf853}
}
EUVIMED